Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells

Hematological Oncology(2022)10.1002/hon.3045Source: DataRank Database

Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells is a research paper published in Hematological Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.39)OA: hybridTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Xiaoyan Hu,Lin Li ORCID,Jewel Nkwocha ORCID,Toshihisa Satta ORCID,Kanika Sharma ORCID

Live enrichment

PubMed:35789025 PMC:PMC10084357 OpenAlex:https://openalex.org/W4283804992

National Institutes of Health

Grant: P30CA16059

National Institutes of Health

Grant: R01CA205607

National Institutes of Health

Grant: UM1CA186644

National Institutes of Health

Grant: 3UM1CA186644-06S1

North American Star Consortium

National Institutes of Health

Grant: 4P30CA016059-35

Massey Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA205607-04

Targeting Multiple Myeloma with Smac-mimetics and HDAC Inhibitors

FWCI

0.39

Citation Percentile

0.5%

Citation Trend

2022

2023

2024

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.3045

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.3045

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3045

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hon.3045

journalhttps://doi.org/10.1002/hon.3045

Fields of Study

Cell death mechanisms and regulationNF-κB Signaling PathwaysDrug-Induced Hepatotoxicity and Protection0301 basic medicine03 medical and health sciencesHumansBortezomibLigandsNF-kappa BTumor Necrosis FactorsApoptosis

MeSH Terms

BortezomibHumansLigandsNF-kappa BApoptosisTumor Necrosis Factors

Keywords

BortezomibApoptosisCancer researchTumor necrosis factor alphaBiologyMedicineChemistryMultiple myelomaImmunologyBiochemistryTRAILCptNon-canonical Nf-κb PathwayIntrinsic/extrinsic ApoptoticTumor Necrosis FactorsNF-kappa BHumansOriginal ArticlesLigands

Sustainable Development Goals

SDG 0: Good health and well-being